Topic: Pharma investing

ZS Pharma

Buyers eye Relypsa and its hyperkalemia drug

Redwood City, CA-based Relypsa has hired an investment bank to check out M&A offers, Reuters reported. Relypsa isn't commenting but the news service says several companies that had previously bid on ZS Pharma, including Actelion, are eyeing Relypsa.